Stimulated Salivary Pertechnetate Clearance Revisited: Correlation with Dynamic Scintigraphic Indices in Sicca Syndrome

PURPOSEThe stimulated salivary clearance of Tc-99m pertechnetate (SSCP) introduced in 1985 by Blue and Jackson is revisited here in patients with known or possible salivary disorders and correlated with most commonly cited and up-to-date quantitative indices obtained from standard dynamic salivary s...

Full description

Saved in:

Bibliographic Details
Published in:	Clinical nuclear medicine Vol. 25; no. 11; pp. 888 - 894
Main Authors:	DEMANGEAT, ROMAIN, S, D D, DIDON-PONCELET, ANNE, CHERFAN, JEAN, DEMANGEAT, JEAN-LOUIS
Format:	Journal Article
Language:	English
Published:	Philadelphia, PA Lippincott Williams & Wilkins, Inc 01-11-2000 Hagerstown, MD Lippincott
Subjects:	Adult Aged Biological and medical sciences Ent. Stomatology Female Humans Investigative techniques, diagnostic techniques (general aspects) Male Medical sciences Middle Aged Non tumoral diseases Otorhinolaryngology. Stomatology Radionuclide Imaging Radionuclide investigations Saliva - metabolism Salivary Glands - diagnostic imaging Sjogren's Syndrome - diagnostic imaging Sodium Pertechnetate Tc 99m - pharmacokinetics Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology Radionuclide study Human Indication Technetium Clearance Scintigraphy Sensitivity Salivary gland disease Measurement technique Cohort study Medical imagery Diagnostic aid Comparative study Quantitative analysis
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	PURPOSEThe stimulated salivary clearance of Tc-99m pertechnetate (SSCP) introduced in 1985 by Blue and Jackson is revisited here in patients with known or possible salivary disorders and correlated with most commonly cited and up-to-date quantitative indices obtained from standard dynamic salivary scintigraphy. METHODSAn SSCP test was performed after dynamic salivary scintigraphy in 19 patients with oral or ocular dryness, among whom 7 had Sjögren’s syndrome. Many scintigraphic indices were calculatedsalivary to background ratio (S/B[t]), background-corrected uptake U[t]), maximal uptake (Umax), cumulative gland uptake (CGU), initial slope of the uptake curve (IS), stimulated excretion velocity (SEV), stimulated excretion fraction (SEF), and excreted activity (EA). RESULTSThe SSCP test was well tolerated, except in two patients in whom it had to be interrupted. Clearance values ranged from 5 to 40 ml/minute, with a clear-cut bimodal distribution centered around 15 to 20 ml/minute. Six of the seven patients with Sjögren’s syndrome had values less than 15 ml/minute. SSCP was closely correlated with all uptake indices (S/B, U, Umax, CGU, and IS) and uptake-related indices (EA, IS×SEF) (P < 0.01). A poor correlation was found with the excretion index SEV (P = 0.06) and none with SEF. CONCLUSIONSSSCP is a quick and objective means to investigate the sicca syndrome that may be useful in most clinical situations. It reflects the parenchymatous salivary gland function and will provide a means to assess and predict salivary gland involvement. Dynamic salivary scintigraphy remains necessary in very early stages because of its high sensitivity rate and ability to locate the impaired gland, or in severe stages in which lemon juice could be deleterious.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	0363-9762 1536-0229
DOI:	10.1097/00003072-200011000-00006